Biomarin Pharmaceutical Inc (BMRN)

BMRN (NASDAQ:Drugs) EQUITY
$120.28
pos +0.00
+0.00%
Today's Range: 120.21 - 123.14 | BMRN Avg Daily Volume: 1,525,700
Last Update: 04/24/15 - 3:59 PM EDT
Volume: 0
YTD Performance: 36.01%
Open: $0.00
Previous Close: $122.95
52 Week Range: $55.36 - $133.54
Oustanding Shares: 159,135,697
Market Cap: 19,565,733,946
6-Month Chart
TheStreet Ratings Grade for BMRN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 12 12 11
Moderate Buy 1 1 1 1
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.47 1.44 1.44 1.47
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -133.64
Price Earnings Comparisons:
BMRN Sector Avg. S&P 500
-133.64 0.00 28.22
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
25.86% 103.21% 252.29%
GROWTH 12 Mo 3 Yr CAGR
Revenue 36.90 0.70 0.19
Net Income 0.00 1.49 0.00
EPS 0.00 0.92 0.00
Earnings for BMRN:
EBITDA -0.10B
Revenue 0.75B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (12/15) FY (12/16)
Average Estimate $-0.53 $-0.55 $-2.33 $-1.32
Number of Analysts 9 9 12 12
High Estimate $-0.27 $-0.33 $-1.53 $0.07
Low Estimate $-0.64 $-0.65 $-2.67 $-2.77
Prior Year $-0.27 $-0.19 $-0.77 $-2.33
Growth Rate (Year over Year) -97.94% -188.89% -203.03% 43.54%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Mar 30, 2015 | 5:39 AM EDT

An answer to those asking me what's worth buying.

By

Jim Cramer

 | Mar 27, 2015 | 12:00 PM EDT

You can't help but feel better about both groups.

By

Jim Cramer

 | Mar 23, 2015 | 6:00 AM EDT

Here are healthcare stocks of all shares and sizes with strong charts.

By

Jim Cramer

 | Mar 21, 2015 | 2:30 PM EDT

Own them, or take something off the table?

By

Jim Cramer

 | Mar 18, 2015 | 7:39 AM EDT

A Fed-related dip may be your only hope to get in lower.

By

Jim Cramer

 | Mar 17, 2015 | 6:48 PM EDT

These companies are doing great -- take some profits!

By

Jim Cramer

 | Mar 16, 2015 | 11:57 AM EDT

It shouldn't be possible, but it never seems too late to get in.

By

Jim Cramer

 | Mar 5, 2015 | 4:22 PM EST

Stocks that stabilized yesterday were terrific today.

By

Jim Cramer

 | Mar 4, 2015 | 12:31 PM EST

Sector could regain its leadership role.

By

Jim Cramer

 | Feb 19, 2015 | 11:02 AM EST

Watch this leadership group that's been lagging.

A gravetone doji candle formed on the weekly Facebook (FB) chart. This candle is defined b...
The iPath Bloomberg Sugar SubTR ETN (SGG) is pushing up towards a test of its prior rally ...
We added some call plays on Microsoft and Celgene today on the very strong price action (m...
Juniper Networks is the number three gainer in the S&P 500 today(behind Amazon/Mi...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.